Topical Pain Relief
The new Convenience Pack includes SuturaGel Methylcellulose Base, which is designed to reduce the amount of medication run-off from the treatment area.
An overall lack of quality evidence exists for the use of topical analgesics and anesthetics (creams, gels and patches) as a therapeutic method for treating chronic pain, according to a new review published in the journal Dermatitis.
St. Renatus announced that the Food and Drug Administration (FDA) has approved Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray, the first dental anesthetic administered as a nasal spray.
Transdermal buprenorphine may be an effective therapy for diabetic peripheral neuropathic pain (DPNP), however it was associated with a high rate of adverse events, mostly nausea and/or vomiting.
The FDA has accepted for filing the New Drug Application for ZTlido (lidocaine patch 1.8%; Scilex) for the treatment of postherpetic neuralgia.
Marathon Pharmaceuticals announced positive results from the Phase 3 study of Zingo (lidocaine hydrochloride monohydrate) for the reduction of venous access pain in pediatric patients.
Capsaicin may be a treatment option for patients with idiopathic non-allergic rhinitis, concluded study authors from the Cochrane Ears, Nose and Throat Group.
Marathon announced the launch of Zingo (lidocaine HCl monohydrate) powder intradermal injection system for the management of venous access pain.
Galen US Incorporated announced that the FDA has approved Synera (lidocaine and tetracaine) topical patch to be used at home for the prevention of needle stick pain associated with superficial IVs and superficial dermatological procedures
Quest Products has announced that it will now distribute Alocane Emergency Burn Gel (Lidocaine HCl 4%), a topical gel for pain and itch relief.
IGI Laboratories announced it has received approval from the FDA for its Abbreviated New Drug Application (ANDA) for Lidocaine HCl USP 4% Topical Solution.
Preliminary evidence indicates that acupuncture may decrease perceived pain in children and adolescents following tonsillectomy.
Pain ratings for the placebo site were significantly lower compared with the control site across both treatment groups, despite identical thermal stimulation.
Dual continuous epidural analgesia (CEA) is the most effective pain control method following surgery for adolescent idiopathic scoliosis.
Actavis announced the launch of Lidocaine Topical Patch 5%, the generic version of Endo Pharmaceutical's Lidoderm.
The FDA has granted Fast Track designation to Elorac's naloxone topical lotion, an opiate antagonist with no agonist activity, for the relief of pruritus in patients with cutaneous T-cell lymphoma.
Topical anesthetic Pliaglis Cream is now available as a local analgesic for superficial dermatological procedures such as dermal filler injection and pulsed dye laser therapy.